Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Ovarian Neoplasms 8Neuroblastoma 8Carcinoma, Ovarian Epithelial 6Uterine Cervical Neoplasms 4Fallopian Tube Neoplasms 4Sarcoma 3Leukemia 3Ganglioneuroblastoma 3Central Nervous System Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Brenner Tumor 2Brain Neoplasms 2Wilms Tumor 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrence 1Pleuropulmonary blastoma 1Optic Nerve Glioma 1Neoplasms, Unknown Primary 1Meningeal Carcinomatosis 1Medulloblastoma 1Malignant mesenchymal tumor 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Lung Neoplasms 1Localized Extraskeletal Ewing Sarcoma 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Juvenile 1

Interventions

Topotecan 1Podophyllotoxin 1Platinum 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Extensive Stage Small Cell Lung Cancer × Topotecan × Clear all
NCT00057837 2023-07-05

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
140 enrolled 8 charts
Thoracic

Extensive Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡